Insulet Corporation (PODD) Valuation — DCF & Advanced Analysis | MarketCI

PODD

Market Closed

Insulet Corporation

NASDAQHealthcare Medical - Devices

5.40K employees

CEO: Ashley A. McEvoy

Founded: 2007

$145.76

+$0.00(+NaN%)

Market Cap

10.10B

Beta

1.13

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: Insulet’s current price of $145.76 exceeds the PERT-weighted fair value of $118.78, indicating overvaluation by 18.5%. Divergence among valuation methods, notably negative DCF versus high analyst targets, reveals conflicting expectations. Strong financial health and zero downside risk in Monte Carlo analysis support stability despite valuation headwinds.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PODD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples